However, recent therapeutic advances in reperfusion therapies, such as intravenous (IV) administration of recombinant tissue plasminogen activator (t-PA) and neuroendovascular treatment (e.g., mechanical thrombectomy) [1,2,3], have allowed some stroke patients to recover without sequelae. The gene discussed is PLAT; the disease is Stroke.